Johnson & Johnson (
) will begin trading ex-dividend on May 22, 2014. A cash dividend
payment of $0.7 per share is scheduled to be paid on June 10, 2014.
Shareholders who purchased JNJ stock prior to the ex-dividend date
are eligible for the cash dividend payment. This represents an
6.06% increase over the prior quarter. At the current stock price
of $100.25, the dividend yield is 2.79%.
The previous trading day's last sale of JNJ was $100.25,
representing a -1.7% decrease from the 52 week high of $101.98 and
a 22.08% increase over the 52 week low of $82.12.
JNJ is a part of the Health Care sector, which includes
companies such as Novartis AG (
) and Pfizer, Inc. (
). JNJ's current earnings per share, an indicator of a company's
profitability, is $5.24. Zacks Investment Research reports JNJ's
forecasted earnings growth in 2014 as 6.6%, compared to an industry
average of 1.7%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to JNJ through an Exchange
Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- iShares U.S. Pharmaceutical ETF (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- Vanguard Health Care ETF (
The top-performing ETF of this group is PPH with an increase of
12.59% over the last 100 days. It also has the highest percent
weighting of JNJ at 9.77%.